Product category:
Engineering Business News and Views
News Release from: ARC Advisory Group
Edited by the Engineeringtalk Editorial
Team on 07 October 2002
Consulting services expand
ARC Advisory Group has expanded its strategic consulting services to include a team dedicated to the pharmaceutical and biotech industries.
ARC Advisory Group has expanded its strategic consulting services to include a team dedicated to the pharmaceutical and biotech industries This expansion provides services for the issues facing pharmaceutical-biotech clinical research and manufacturing, commercial manufacturing, and suppliers of automation technology
This article was originally published on Engineeringtalk on 10 Nov 2004 at 8.00am (UK)
Related stories
Capex in power industry continues to grow
Worldwide capital and operational expenditures for plants in the electric power industry, which totalled more than $374 billion in 2003, will exceed $453 billion by the end of 2008.
Natural gas boosts Coriolis flowmeter market
The worldwide market for Coriolis flowmeters is expected to grow at a CAGR of 8.9% over the next five years, according to a new study.
The high financial investment coupled with the diversity of new treatments increases risk and drives the need for industry knowledgeable strategic consulting.
With a 12 to 15 year product development cycle costing over $800 million to bring a single drug to market, companies in this industry have many business, supply chain, and manufacturing issues that are unique.
They require specialized knowledge and expertise in regulatory requirements, automation technology, and business best practices.
New drugs and treatments were made possible by tremendous scientific progress in biotechnology, biochemistry, and genetic engineering.
Global awareness creates a high demand for the latest life improving drugs.
These issues plus the demand for cost containment, a wider variety of affordable drugs, and increasing regulatory costs, are redefining the health care industry.
This includes closer relationships with suppliers, closer collaboration from drug development through clinical trials and commercial manufacturing, and the use of leading edge technologies to improve the entire business supply chain and manufacturing processes.
ARC is unique in its ability to provide strategic consulting to pharmaceutical companies so they can better respond to their changing market requirements.
ARC's Pharmaceutical-BioTech Consulting Practice covers logistics, supply chain, automation, control system integration, batch management, regulatory requirements, advanced control, and optimization applications.
Supplier and users alike are focused on the FDA's 21 CFR Part 11 requirements and new drug validation.
Manufacturers in the FDA-regulated industries get a better understanding of currently available technologies and services to help them determine how to meet 21 CFR Part 11 requirements and speed validation.
• ARC Advisory Group: contact details and other news
• Email this article to a colleague
• Register for the free Engineeringtalk email newsletter
• Engineeringtalk Home Page
Search the Pro-Talk network of sites
